These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 9457037

  • 1. The effect of curcumin on human B-cell immortalization by Epstein-Barr virus.
    Ranjan D, Siquijor A, Johnston TD, Wu G, Nagabhuskahn M.
    Am Surg; 1998 Jan; 64(1):47-51; discussion 51-2. PubMed ID: 9457037
    [Abstract] [Full Text] [Related]

  • 2. Cyclosporine directly causes oxidative stress and promotes Epstein-Barr virus transformation of human B cells.
    Chen C, Johnston TD, Reddy KS, Merrick JC, Mastrangelo M, Ranjan D.
    J Surg Res; 2001 Oct; 100(2):166-70. PubMed ID: 11592787
    [Abstract] [Full Text] [Related]

  • 3. Enhanced apoptosis mediates inhibition of EBV-transformed lymphoblastoid cell line proliferation by curcumin.
    Ranjan D, Johnston TD, Reddy KS, Wu G, Bondada S, Chen C.
    J Surg Res; 1999 Nov; 87(1):1-5. PubMed ID: 10527697
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporin A up-regulates and activates protein kinase C-zeta in EBV-infected and EBV-transformed human B-cells.
    Chen C, Johnston TD, Jeon H, Gedaly R, McHugh P, Ranjan D.
    J Surg Res; 2009 May 01; 153(1):156-61. PubMed ID: 18486150
    [Abstract] [Full Text] [Related]

  • 5. Curcumin blocks cyclosporine A-resistant CD28 costimulatory pathway of human T-cell proliferation.
    Ranjan D, Johnston TD, Wu G, Elliott L, Bondada S, Nagabhushan M.
    J Surg Res; 1998 Jul 01; 77(2):174-8. PubMed ID: 9733605
    [Abstract] [Full Text] [Related]

  • 6. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R.
    Autoimmun Rev; 2007 Dec 01; 7(2):96-101. PubMed ID: 18035317
    [Abstract] [Full Text] [Related]

  • 7. Cyclosporine promotes epstein-barr virus-infected human B-cell transformation assayed by three correlated assay methods.
    Chen C, Johnston TD, Jeon H, Gedaly R, McHugh P, Ranjan D.
    Transplant Proc; 2009 Dec 01; 41(1):366-70. PubMed ID: 19249558
    [Abstract] [Full Text] [Related]

  • 8. Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
    Tanner JE, Alfieri C.
    Leuk Lymphoma; 1996 May 01; 21(5-6):379-90. PubMed ID: 9172802
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells.
    Markasz L, Stuber G, Flaberg E, Jernberg AG, Eksborg S, Olah E, Skribek H, Szekely L.
    BMC Cancer; 2006 Nov 13; 6():265. PubMed ID: 17101045
    [Abstract] [Full Text] [Related]

  • 10. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH, Kim HR, Kim J, Jang SH, Lee KY, Chung GH, Jang YS.
    J Cell Biochem; 2004 Mar 01; 91(4):777-85. PubMed ID: 14991769
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-6 and Epstein-Barr virus induction by cyclosporine A: potential role in lymphoproliferative disease.
    Tanner JE, Menezes J.
    Blood; 1994 Dec 01; 84(11):3956-64. PubMed ID: 7949151
    [Abstract] [Full Text] [Related]

  • 12. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
    Shaknovich R, Basso K, Bhagat G, Mansukhani M, Hatzivassiliou G, Murty VV, Buettner M, Niedobitek G, Alobeid B, Cattoretti G.
    Haematologica; 2006 Oct 01; 91(10):1313-20. PubMed ID: 17018379
    [Abstract] [Full Text] [Related]

  • 13. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR, Nalesnik MA, Swerdlow SH.
    Am J Surg Pathol; 2006 Dec 01; 30(12):1604-12. PubMed ID: 17122518
    [Abstract] [Full Text] [Related]

  • 14. A peptide-based inhibitor for prevention of B cell hyperproliferation induced by Epstein-Barr virus.
    Knight JS, Lan K, Bajaj B, Sharma N, Tsai DE, Robertson ES.
    Virology; 2006 Oct 10; 354(1):207-14. PubMed ID: 16876848
    [Abstract] [Full Text] [Related]

  • 15. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
    Loomis R, Carbone R, Reiss M, Lacy J.
    Clin Cancer Res; 2003 May 10; 9(5):1931-9. PubMed ID: 12738752
    [Abstract] [Full Text] [Related]

  • 16. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R.
    G Ital Nefrol; 2003 May 10; 20(2):170-5. PubMed ID: 12746803
    [Abstract] [Full Text] [Related]

  • 17. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan 10; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
    Bräuninger A, Spieker T, Mottok A, Baur AS, Küppers R, Hansmann ML.
    Eur J Immunol; 2003 Jun 10; 33(6):1593-602. PubMed ID: 12778477
    [Abstract] [Full Text] [Related]

  • 19. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
    Suzuki T, Piche A, Kasono K, Xiang J, Gomez-Navarro J, Moriuchi S, Krisky DM, Oligino T, Glorioso JC, Curiel TJ, Curiel DT.
    Biochem Biophys Res Commun; 1998 Nov 27; 252(3):686-90. PubMed ID: 9837767
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T, Yachie A, Kanegane H, Kimura H, Shiobara S, Nakao S.
    Am J Hematol; 2003 Apr 27; 72(4):255-8. PubMed ID: 12666136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.